Canada markets closed

Aida Pharmaceuticals, Inc. (AIDA)

OTC Markets EXMKT - OTC Markets EXMKT Delayed Price. Currency in USD
Add to watchlist
0.00020.0000 (0.00%)
At close: 09:37AM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 8.37M
Enterprise Value 8.37M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.17
Price/Book (mrq)0.77
Enterprise Value/Revenue 0.21
Enterprise Value/EBITDA 3.43

Trading Information

Stock Price History

Beta (5Y Monthly) 16.71
52-Week Change 30.00%
S&P500 52-Week Change 326.25%
52 Week High 30.0002
52 Week Low 30.0001
50-Day Moving Average 30.0002
200-Day Moving Average 30.0002

Share Statistics

Avg Vol (3 month) 3160
Avg Vol (10 day) 311
Shares Outstanding 5N/A
Implied Shares Outstanding 641.85B
Float 8N/A
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 25:4
Last Split Date 3Nov 30, 2005

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2007
Most Recent Quarter (mrq)Sept 30, 2008

Profitability

Profit Margin -5.38%
Operating Margin (ttm)21.30%

Management Effectiveness

Return on Assets (ttm)6.62%
Return on Equity (ttm)-1.79%

Income Statement

Revenue (ttm)40.51M
Revenue Per Share (ttm)1.50
Quarterly Revenue Growth (yoy)61.20%
Gross Profit (ttm)N/A
EBITDA 9.51M
Net Income Avi to Common (ttm)-2.18M
Diluted EPS (ttm)-0.0000
Quarterly Earnings Growth (yoy)341.10%

Balance Sheet

Total Cash (mrq)8.28M
Total Cash Per Share (mrq)0.31
Total Debt (mrq)41.17M
Total Debt/Equity (mrq)237.46%
Current Ratio (mrq)0.73
Book Value Per Share (mrq)0.34

Cash Flow Statement

Operating Cash Flow (ttm)7.49M
Levered Free Cash Flow (ttm)2.27M